| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
Center for the Study of Inflammatory Bowel Disease, Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114
Submitted 8 August 2003 ; accepted in final form 9 November 2003
Clinical studies have suggested that so-called probiotic bacteria may be effective as therapy in inflammatory bowel disease. However, the molecular mechanisms of their interaction with the intestinal surface remain undefined. The influence of whole probiotic bacteria [Escherichia coli Nissle 1917 (EcN); probiotic mixture VSL#3 (PM)], bacterial cell lysates, and conditioned media on transepithelial resistance (TER), IL-8 secretion, mucin gene expression, and tight junction proteins were determined in T84 and HT-29 intestinal epithelial cells (IEC). In addition, effects on pathogen (Salmonella dublin)-induced alterations were analyzed. EcN as well as debris and cell extracts induced IL-8 secretion from IEC, whereas no such effect was observed following incubation with the PM. The PM and soluble protein(s) released from the PM increased TER, prevented pathogen-induced decrease in TER, and were shown to stabilize tight junctions. The PM induced expression of mucins in IEC, and these organisms as well as EcN diminished S. dublin-induced cell death. Inhibition of MAPKs with PD-98059 or SB-203580 significantly decreased alterations in IL-8 synthesis and mucin expression and affected the regulation of TER. Probiotics and protein(s) released by these organisms may functionally modulate the intestinal epithelium of the host by different mechanisms, including the competition of whole organisms for contact with the epithelial surface as well as stabilization of the cytoskeleton and barrier function and the induction of mucin expression. Gram-negative and gram-positive organisms differ in the mechanisms activated, and a combination of organisms might be more effective than the application of a single strain.
probiotics; Escherichia coli Nissle 1917; probiotic mixture VSL#3; intestinal epithelial cell lines; interleukin-8; transepithelial resistance; zonula occludens-1; mucins
This article has been cited by other articles:
|
|
 |
|
  L. Khailova, K. Dvorak, K. M. Arganbright, M. D. Halpern, T. Kinouchi, M. Yajima, and B. Dvorak Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G940 - G949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fleige, W. Preissinger, H. H. D. Meyer, and M. W. Pfaffl The immunomodulatory effect of lactulose on Enterococcus faecium fed preruminant calves J Anim Sci, May 1, 2009; 87(5): 1731 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lebeer, J. Vanderleyden, and S. C. J. De Keersmaecker Genes and Molecules of Lactobacilli Supporting Probiotic Action Microbiol. Mol. Biol. Rev., December 1, 2008; 72(4): 728 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chichlowski and L. P. Hale Bacterial-mucosal interactions in inflammatory bowel disease--an alliance gone bad Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1139 - G1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Myllyluoma, A.-M. Ahonen, R. Korpela, H. Vapaatalo, and E. Kankuri Effects of Multispecies Probiotic Combination on Helicobacter pylori Infection In Vitro Clin. Vaccine Immunol., September 1, 2008; 15(9): 1472 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Candela, G. Miccoli, S. Bergmann, S. Turroni, B. Vitali, S. Hammerschmidt, and P. Brigidi Plasminogen-dependent proteolytic activity in Bifidobacterium lactis Microbiology, August 1, 2008; 154(8): 2457 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. O. Canny and B. A. McCormick Bacteria in the Intestine, Helpful Residents or Enemies from Within? Infect. Immun., August 1, 2008; 76(8): 3360 - 3373. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Borthakur, R. K. Gill, S. Tyagi, A. Koutsouris, W. A. Alrefai, G. A. Hecht, K. Ramaswamy, and P. K. Dudeja The Probiotic Lactobacillus acidophilus Stimulates Chloride/Hydroxyl Exchange Activity in Human Intestinal Epithelial Cells J. Nutr., July 1, 2008; 138(7): 1355 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Sun, H. Yang, K. Nose, S. Nose, E. Q. Haxhija, H. Koga, Y. Feng, and D. H. Teitelbaum Decline in intestinal mucosal IL-10 expression and decreased intestinal barrier function in a mouse model of total parenteral nutrition Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G139 - G147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roselli, A. Finamore, M. S. Britti, S. R. Konstantinov, H. Smidt, W. M. de Vos, and E. Mengheri The Novel Porcine Lactobacillus sobrius Strain Protects Intestinal Cells from Enterotoxigenic Escherichia coli K88 Infection and Prevents Membrane Barrier Damage J. Nutr., December 1, 2007; 137(12): 2709 - 2716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Isakow, L. E. Morrow, and M. H. Kollef Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations Chest, July 1, 2007; 132(1): 286 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kohler, T. Sakaguchi, B. P. Hurley, B. J. Kase, H.-C. Reinecker, and B. A. McCormick Salmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passage Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G178 - G187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Caballero-Franco, K. Keller, C. De Simone, and K. Chadee The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G315 - G322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Daniel, S. Poiret, D. Goudercourt, V. Dennin, G. Leyer, and B. Pot Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model Appl. Envir. Microbiol., September 1, 2006; 72(9): 5799 - 5805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A-P Bai and Q Ouyang Probiotics and inflammatory bowel diseases. Postgrad. Med. J., June 1, 2006; 82(968): 376 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Cario BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2 Gut, August 1, 2005; 54(8): 1182 - 1193. [Full Text] [PDF]
|
|
|
|
|
|
P Gionchetti, K M Lammers, F Rizzello, and M Campieri Probiotics and barrier function in colitis Gut, July 1, 2005; 54(7): 898 - 900. [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, N. Li, R. Caicedo, and J. Neu Alive and Dead Lactobacillus rhamnosus GG Decrease Tumor Necrosis Factor-{alpha}-Induced Interleukin-8 Production in Caco-2 Cells J. Nutr., July 1, 2005; 135(7): 1752 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wehkamp, M. Schmid, K. Fellermann, and E. F. Stange Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease J. Leukoc. Biol., April 1, 2005; 77(4): 460 - 465. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
